Michigan Medicine’s Department of Emergency Medicine is developing a low-cost, antimicrobial mouthguard to prevent ventilator-associated pneumonia (VAP), a deadly hospital-acquired infection. This simple device absorbs harmful secretions before they reach the lungs, potentially reducing ICU stays and healthcare costs. Read on to learn how this innovation could improve patient outcomes not just in hospitals, but also in ambulances and even on the battlefield.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.